Overview

Effectiveness of ATMX in Treating Adolescents With ADHD and SUD

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
Adolescents with attention deficit hyperactivity disorder (ADHD) often develop substance use disorders (SUD). The purpose of this study is to evaluate the effectiveness of atomoxetine in treating adolescents dually diagnosed with ADHD and SUD.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Atomoxetine Hydrochloride